Laurion Capital Management »

Cytek Biosciences shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $99k 22k 4.43

More positions owned by Laurion Capital Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Advanced Micro Devices Call Option (AMD)
Norfolk Southern (NSC)
Electronic Arts (EA)
Applied Materials Call Option (AMAT)
Dell Technologies CL C (DELL)
Warner Bros Discovery Com Ser A (WBD)
Corning Incorporated Call Option (GLW)
Bridgebio Pharma (BBIO)
Robinhood Mkts Com Cl A (HOOD)
Datadog Cl A Com Call Option (DDOG)
Carvana Cl A (CVNA)
Qualcomm (QCOM)
Intel Corporation Call Option (INTC)
Cloudflare Cl A Com Call Option (NET)

View all positions for Laurion Capital Management

Top funds holding Cytek Biosciences

BlackRock
Millennium Management
Robeco Investment Management
Hillhouse Capital Advisors
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Goldman Sachs Group
Royce & Associates
Morgan Stanley
Russell Investments
Acadian Asset Management
Bank of America Corporation
Vanguard Portfolio Management

View all funds holding Cytek Biosciences